Gustavo Frechtel
Overview
Explore the profile of Gustavo Frechtel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frechtel G, Sauque-Reyna L, Choza-Romero R, Anguiano L, Melas-Melt L, Sanudo-Maury M
Diabetes Obes Metab
. 2023 May;
25(9):2526-2534.
PMID: 37253689
Aims: This subanalysis of the SoliMix trial assessed the efficacy and safety of advancing basal insulin (BI) therapy with iGlarLixi versus BIAsp 30 in people with type 2 diabetes (T2D)...
2.
Sethi B, Al-Rubeaan K, Unubol M, Mabunay M, Berthou B, Pilorget V, et al.
Diabetes Ther
. 2022 Jun;
13(7):1395-1408.
PMID: 35713873
Introduction: The efficacy and safety of switching to insulin glargine 300 U/mL (Gla-300) in type 2 diabetes mellitus (T2DM) uncontrolled on basal insulin (BI) has been demonstrated in the North...
3.
Frechtel G, Forti L, Faingold C, Perez Mangui F, Orio S, Issa C, et al.
Endocrinol Diabetes Metab
. 2021 Feb;
4(1):e00164.
PMID: 33532606
Aim: To describe in a real-world setting, the proportion of patients with a symptomatic hypoglycaemic event and the proportion of individuals with type 2 diabetes, who newly or recently initiated...
4.
Lozano Chiappe E, Martin M, Iglesias Molli A, Millan A, Tetzlaff W, Botta E, et al.
Obes Surg
. 2020 Oct;
31(3):1092-1098.
PMID: 33128217
Purpose: Morbid obesity represents the most severe form of obesity and surgical intervention would be its only successful treatment. Bariatric surgery could generate modifications in carbohydrate metabolism and in lipid...
5.
Martin M, Millan A, Ferraro F, Tetzlaff W, Lozano C, Botta E, et al.
Biosci Rep
. 2020 Oct;
40(10).
PMID: 33026063
Background: Hereditary hemochromatosis (HH) is a primary iron overload (IO) condition. Absolute telomere length (ATL) is a marker of cellular aging and DNA damage associated with chronic diseases and mortality....
6.
Yohena S, Penas-Steinhardt A, Muller C, Faccinetti N, Cerrone G, Lovecchio S, et al.
Diabetes Metab Res Rev
. 2019 Feb;
35(5):e3137.
PMID: 30743316
Background: Latent autoimmune diabetes in adults (LADA) is determined by both a noninsulin-dependent clinical presentation and an autoimmune pathogenic process. Glutamic acid decarboxylase antibody (GADA) constitutes the most important marker,...
7.
Etulain J, Mena H, Meiss R, Frechtel G, Gutt S, Negrotto S, et al.
Sci Rep
. 2018 Jan;
8(1):1513.
PMID: 29367608
Although platelet-rich plasma (PRP) is used as a source of growth factors in regenerative medicine, its effectiveness remains controversial, partially due to the absence of PRP preparation protocols based on...
8.
Carestia A, Frechtel G, Cerrone G, Linari M, Gonzalez C, Casais P, et al.
PLoS One
. 2016 Dec;
11(12):e0168647.
PMID: 28005949
Introduction And Objective: Diabetes is characterized by chronic inflammation, endothelial dysfunction, increased risk of infections and early cardiovascular disease. By releasing neutrophil extracellular traps (NETs), neutrophils kill bacteria and exert...
9.
de Lapertosa S, Frechtel G, Hardy E, Sauque-Reyna L
Diabetes Res Clin Pract
. 2016 Oct;
122:38-45.
PMID: 27776251
Aims: Socioeconomic changes in Latin American countries have led to an increased prevalence of type 2 diabetes (T2D). We examined the effects of exenatide twice daily (BID) or insulin lispro,...
10.
Cardoso Landaburu A, Pomares M, Avalos A, Lapertosa S, Frechtel G, Poskus E
MethodsX
. 2016 Sep;
3:502-7.
PMID: 27617231
The prevalence and high levels of anti-insulin antibodies (IA) have frequently been associated with brittle diabetes, lipodystrophy in the areas where the insulin is injected and/or poor metabolic control. When...